Marathon Capital Management Abiomed Inc Transaction History

Marathon Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$277.25 - $366.29 $207,937 - $274,717	-750 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $7,881 - $10,535	-30 Reduced 3.85%	750 $234,000
Q4 2020 Feb 08, 2021	BUY	$251.88 - $324.2 $1,259 - $1,621	5 Added 0.65%	780 $252,000
Q3 2020 Nov 16, 2020	BUY	$255.22 - $317.0 $197,795 - $245,675	775 New	775 $214,000
Q2 2019 Jul 25, 2019	SELL	$250.96 - $284.94 $195,748 - $222,253	-780 Closed	0 $0

Q4 2018 Feb 07, 2019	BUY	$281.08 - $444.25 $8,432 - $13,327	30 Added 4.0%	780 $253,000
Q3 2018 Nov 13, 2018	SELL	$354.53 - $449.75 $52,824 - $67,012	-149 Reduced 16.57%	750 $337,000
Q2 2018 Aug 07, 2018	SELL	$278.07 - $446.21 $28,085 - $45,067	-101 Reduced 10.1%	899 $367,000
Q1 2018 May 07, 2018	BUY	$192.49 - $295.85 $192,490 - $295,850	1,000 New	1,000 $290,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

Stay updated on Marathon Capital Management with notifications on news.